Project D419LC00001 – A Phase III Randomized, Open-label, Multi-center, Global Study of MEDI4736 in Combination with…

Basic data

Acronym:
D419LC00001
Title:
A Phase III Randomized, Open-label, Multi-center, Global Study of MEDI4736 in Combination with Tremelimumab versus Standard of Care in the Treatment of First-line Recurrent or Metastatic Squamous Cell Head and Neck Cancer Patients
Duration:
18/01/2016 to 17/01/2021
Abstract / short description:
A Phase III Randomized, Open-label, Multi-center, Global Study of MEDI4736 in Combination with Tremelimumab versus Standard of Care in the Treatment of First-line Recurrent or Metastatic Squamous Cell Head and Neck Cancer Patients
Keywords:
clinical trial
klinische Studie

Staff

Managers

Faculty of Medicine
University of Tübingen

Contact persons

Department of Radiology
Hospitals and clinical institutes, Faculty of Medicine

Local organizational units

Department of Diagnostic and Interventional Radiology
Department of Radiology
Hospitals and clinical institutes, Faculty of Medicine

Funders

Wedel, Schleswig-Holstein, Germany
Help

will be deleted permanently. This cannot be undone.